Scott Kellen - CFO and Secretary, Diamedica Therapeutics Inc
As of June 2, 2022
What is Scott Kellen's Net Worth?
The current estimated net worth of Diamedica Therapeutics Inc's CFO and Secretary, Scott Kellen, is estimated to be about $55.5K . Scott Kellen owns about 22,290 units of Diamedica Therapeutics Inc common stock. In the last 4 years at Diamedica Therapeutics Inc, Scott Kellen has sold an estimated value of $0 worth.
What is Scott Kellen's Past Insider Trading?
Scott Kellen's largest purchase order was 10,000 units , worth over $31.46K on August 16, 2021. In total, Scott Kellen has made about 9 transactions over 4 years of their time at Diamedica Therapeutics Inc. Scott Kellen usually trades in June, with the busiest year in 2019.
Scott Kellen
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Scott Kellen's Salary in 2020?
As CFO and Secretary of Diamedica Therapeutics Inc, Scott Kellen has a total base salary of $276,075 . Scott Kellen received compensation valued at about $489,303 in 2020 after becoming CFO and Secretary. The vast majority of their compensation came in the form of option awards of $119,140 , other earnings, plans or compensations of $79,238 , and other compensation of $14,850 .
What is Scott Kellen's' Mailing Address?
- Mailing address is 3405 Annapolis Lane Suite 200 Minneapolis MN 55447 MN
Diamedica Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Rick Pauls | 2020 | $455,013 | - | $190,624 | $217,716 | $14,850 | $878,203 |
| Rick Pauls | 2019 | $420,000 | - | $890,736 | $178,000 | $14,650 | $733,707 |
| Scott Kellen | 2020 | $276,075 | - | $119,140 | $79,238 | $14,850 | $489,303 |
| Scott Kellen | 2019 | $262,500 | - | $336,557 | $64,800 | $13,950 | $677,807 |
| Harry Alcorn, Jr., Pharm.D. | 2020 | $291,413 | - | $119,140 | $83,662 | $14,850 | $509,065 |
| Harry Alcorn, Jr., Pharm.D. | 2019 | $273,750 | - | $421,750 | $68,400 | $14,400 | $778,300 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1401040/000143774921014066/dmtp20210406_def14a.htm
What are Diamedica Therapeutics Inc's Past Insider Trades?
Diamedica Therapeutics Inc's most recent insider trade came on September 15, 2021 by Harry Alcorn Jr who bought 15,000 units worth $56.96K . In the last 3 years, insiders at Diamedica Therapeutics Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Richard Pilnik, Director, Scott Kellen, CFO and Secretary, and Harry Alcorn Jr, SVP .
DiaMedica Therapeutics Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||